Opinion
Video
PALISADE Study: Plozasiran’s Efficacy and Potential in Reducing Triglycerides and Pancreatitis
Panelists discuss how a multidisciplinary approach enhances the management of familial chylomicronemia syndrome by fostering collaboration among clinicians to address unmet treatment needs and optimize patient outcomes, while also exploring existing treatment gaps that contribute to ongoing risks of acute pancreatitis and hospitalization.
Video content above is prompted by the following:
What role does a multidisciplinary approach play in the management of familial chylomicronemia syndrome (FCS)? How can clinicians collaborate to optimize patient outcomes and address unmet needs in treatment and care?
- What does a typical care team look like for an FCS patient? Are there differences between countries/regions?
What are the gaps in existing treatments for FCS in terms of reducing triglyceride levels, and how do these gaps contribute to the risk of acute pancreatitis and the need for hospitalization?
